This page does not choose an agent. It shows what each source says, with the kind of evidence beside it.
Pick a condition. Neonate, nonemergency shows the newborn premedication statement as well.
No randomized trial of an induction agent in children with heart disease was found: the condition panels rest on cohorts, small studies, reviews and a textbook. kind of evidence abstract = read in the abstract only.
Not addressed in the sources read: etomidate, dexmedetomidine.
Not addressed in the sources read: propofol, midazolam, dexmedetomidine, the muscle relaxants, atropine.
Not addressed in the sources read: etomidate, midazolam, atropine.
A 2026 Surviving Sepsis update exists; its wording is not shown here. Not addressed: dexmedetomidine.
No source read names an induction agent to use or avoid in obstructive HCM.
No source read names an induction agent for Williams syndrome. Surveillance and anesthesia planning: Syndrome surveillance.
No study of induction agents in single ventricle was found. Not addressed: propofol, midazolam, dexmedetomidine.
Not addressed in the sources read: etomidate, propofol, fentanyl, midazolam, dexmedetomidine.
Check every dose against your formulary. Doses are in the closed box under each drug, each with its source and the age it applies to.
| Drug | SVR | PVR | Contractility | Heart rate | Watch for |
|---|---|---|---|---|---|
| Ketamine | ↑ (textbook); no significant change in small studies | No significant change; minimal (AHA/ATS 2015) | Direct depressant; sympathetic release (textbook) | ↑ (textbook, label) | Contraindicated where a blood pressure rise is a serious hazard (label) |
| Etomidate | No significant change (Sarkar 2005, Dhawan 2010) | No significant change (Sarkar 2005) | n/s; cardiac output little changed (label) | No significant change (Dhawan 2010) | Adrenal suppression after one dose; under 10 y not recommended (label) |
| Propofol | ↓ (textbook) | Minimal (AHA/ATS 2015) | ↓ (textbook) | Bradycardia, asystole reported (label) | Hypotension; induction under 3 y not recommended (label) |
| Midazolam | n/s | n/s | n/s | With fentanyl, lower output through lower rate (textbook) | Hypotension; no analgesia; not alone in neonates (CPS 2026) |
| Fentanyl | Small ↓ (Hickey 1985, fentanyl) | No significant change; blunts the rise with suctioning | Cardiac index unchanged (Hickey 1985, fentanyl) | Bradycardia (textbook, label) | Chest wall rigidity: give slowly (CPS 2026, label) |
| Dexmedetomidine adjunct | ↑ with loading dose or bolus | No significant change | Cardiac index unchanged (Friesen 2013) | ↓; sinus and AV node depressed (Hammer 2008) | Bradycardia, hypertension, hypotension (label) |
| Rocuronium | n/s | n/s | n/s | Transient rise after intubation without atropine (label) | Not recommended for pediatric rapid sequence intubation (label) |
| Succinylcholine | n/s | n/s | n/s | Bradycardia, rarely asystole; worse in children (label) | Boxed warning: hyperkalemic arrest with undiagnosed myopathy (label) |
| Atropine | n/s | n/s | n/s | ↑ (Jones 2013) | Neonates: associated with more desaturation, lower first-attempt success (Sawyer 2026, registry) |
Neonates, infants and children with heart disease. Adult data labelled Adult.